{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.30 vs. cons $2.25",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales (revenue)",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.38B vs. cons $4.36B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Segment adj. EBITDA margin (price/cost proof)",
      "prediction": "IN-LINE",
      "answer": "pred ~19.3% vs. cons ~19.4%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 adjusted EPS guide",
      "prediction": "UNCHANGED",
      "answer": "guide ~$7.70-$8.10 (mid ~$7.90) vs. cons $7.90 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 2026 adj. EPS guide (organic/price-cost tone)",
      "prediction": "UNKNOWN",
      "answer": "guide ~$2.15 vs. cons $2.16 (Q3 2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "Refinish H2 volume inflection commentary",
      "prediction": "BETTER",
      "answer": "guide return to volume growth ~+low-single-digit vs. cons ~flat (H2 2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -1.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -2.5,
  "day5_path": "FADE",
  "day5_rationale": "Likely a modest EPS beat aided by a fading FX tailwind and price, but the swing factor is guidance: a reaffirm (not a raise) of $7.70-$8.10 despite management's own 'upside' callouts repeats the post-Q1 pattern (stock fell ~2.8% on a beat). With the stock back near February highs (~$118.50, +14% YTD) and having outrun peers off the March low, the bar is high. Out-period math is unfavorable \u2014 a flat FY reaffirm plus mid-single-digit COGS inflation risk implies limited H2 upside, so estimates drift lower even after a beat, driving a day-1 dip and continued fade over the week absent a clean guidance raise.",
  "day5_confidence": "LOW"
}